{
    "nct_id": "NCT05372003",
    "official_title": "IL-4 & Insulin Resistance in Patients With Atopic Dermatitis",
    "inclusion_criteria": "* Ability to sign informed consent form.\n* Body mass index (BMI), 22-29 kg/m^2.\n* Diagnosis of Atopic Dermatitis treated with dupilumab for longer than 6 months.\n* Diagnosis of Atopic Dermatitis treated with topical steroids or phototherapy.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 60 Years",
    "exclusion_criteria": "* Any prescription for systemic glucocorticoid, immunosuppressant, antidiabetic medications in the past 6 months.\n* Evidence of diabetes mellitus.\n* Morning Cortisol < 5 mg/dl (collected before 10.30 am).\n* Presence of acute illness.\n* Low hemoglobin or hematocrit.\n* Current participation in a weight-loss regimen, with a weight loss > 10% total body weight in the last 6 months).\n* Smoking history in the last 6 months (tobacco, nicotine-containing products including e-cigarettes).\n* Pregnant or breastfeeding.\n* Personal history of gastric bypass surgery.\n* Previous participation in a clinical trial with an investigational product in the past 30 days, or 5 half-lives, or twice the duration of the biological effect of the investigational drug (whichever is longest).\n* Exposed to more than 4 new chemical entities within 12 months before study enrollment.\n* Any other condition or event considered exclusionary by the PI and the study physician.",
    "miscellaneous_criteria": ""
}